Additional InformationGBI Research’s report, “Aesthetic Devices Market to 2017 - Future Growth to be Driven by Improving Treatment Outcomes and Increase in Consumer Confidence” provides key data, information and analysis on the global aesthetic Devices market. The report provides market landscape, competitive landscape and market trends information on three aesthetic devices market categories - aesthetic lasers and energy devices, breast implants and facial aesthetic devices. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape with major acquisitions and mergers in the last three years and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
The Global Aesthetic Devices Market is Forecast to Reach $3.5 Billion in 2017
The global market for medical aesthetic devices is forecast to reach $3.5 billion in 2017 at a CAGR of 7%. The growth is primarily driven by factors such as competition between the non-core and core physicians that have reduced the overall cost of the aesthetic procedures and the inception of minimally invasive and non-invasive aesthetic procedures. The significant growth of medical aesthetic devices in 2010 is led by the recovery of some of the developed economies after the slowdown experienced in 2009 due to the recession. The market is on an upward trend, due to an increasing desire to look youthful. Lack of reimbursements for aesthetic devices is perceived as a major drawback as this can have a significant effect on the overall growth.
Aesthetic Devices Market, Global, Overall Revenues ($bn), 2010 - 2017
Source: GBI Research
Silicone Breast Implants to Contribute 98% of US Breast Implants Market by 2016
In the US, silicone breast implants are forecast to contribute 98% towards the overall breast implants market in 2016, an increase from the current contribution of 85%. The US silicone breast implants market was valued at $316m in 2009 and is forecast to reach $657.6m in 2016 with a CAGR of 11%. Patients prefer silicone breast implants to saline breast implants as silicone implants feel more like natural breasts and are less prone to wrinkles. Trans umbilical breast augmentation will fuel the growth of silicone breast implants in the US. Since this procedure is minimally invasive it is convenient and patients to enjoy good results. This procedure is expected to replace other breast enhancement procedures owing to its advantages such as prevention of scars around the connective tissues of the breast and capability of completing both the breast implants simultaneously.
Silicone Breast Implants and Saline Breast Implants Share, US, 2017
Source: GBI Research
Allergan and Mentor Lead the Global Aesthetic Devices Market in 2010
Allergan and Mentor lead the medical aesthetic devices market with a combined market share of 40%. While Mentor dominated the market for breast implants and has significant presence in facial aesthetics, Allergan has significant market share in both breast implants and facial aesthetics. Mergers and acquisitions are expected to consolidate the market in the future leading to aesthetic procedures becoming more affordable.
Aesthetic Devices Market, Global, Key Company Shares (%), 2010
Source: GBI Research
More Dermatology reports by GBI Research
Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment by GBI Research
Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis TreatmentSummaryGBI Research, the leading business intelligence provider, has released ...
Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline by GBI Research
Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak PipelineSummaryGBI Research, the ...
Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials by GBI Research
Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical TrialsSummaryGBI Research, the leading business ...
See all reports like this >>
Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers by GBI Research
Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient NumbersSummaryGBI Research’s report ‘Clinical Trial Recruitment in ...